research use only
Cat.No.S8158
| Related Targets | CXCR STING AhR Immunology & Inflammation related CD markers Interleukins Anti-infection Antioxidant COX Histamine Receptor |
|---|---|
| Other PD-1/PD-L1 Inhibitors | AUNP-12 BMS-202 BMS-1 BMS-1166 SR 0987 INCB086550 GS-4224 CA-170 (AUPM-170) BMS-1001 Sanguisorbae Radix Extract |
|
In vitro |
Water : 100 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 1852.17 | Formula | C89H126N24O18S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1629654-95-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CCCCC1C(=O)NC(C(=O)NC(CSCC(=O)NC(C(=O)N(C(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N(CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N1C)CCCC)C)CC3=CNC4=CC=CC=C43)CO)CC5=CNC6=CC=CC=C65)C)CC(C)C)CC7=CN=CN7)CC(=O)N)C)C)CC8=CC=CC=C8)C(=O)NCC(=O)N)CCCNC(=N)N | ||
| Targets/IC50/Ki |
PD-1/PD-L1 interaction
(Cell-free assay) 5.6 nM
|
|---|---|
| In vitro |
PD-1/PD-L1 Inhibitor 3 is capable of inhibiting the interaction of PD-L1 with PD-1 and with CD80. It has highly efficacious binding to PD-L1 and promotes enhanced T cell functional activity. |
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
Could you tell me what the difference is between these products (S7911, S7912, S8158), and do you have any recommendations about which one to select?
Answer:
They are of high purity and can be used for both cell culture and mouse study. S7911 and S7912 are small-molecule inhibitors that have different IC50s, while S8158 is a macrocyclic inhibitor.